The FDA should liberate this birth control pill

Bloomberg covers the unanimous recommendation of a panel of FDA advisors to approve a birth control pill called Opill for over-the-counter use.

Previous
Previous

Over-the-counter birth control access clears final hurdle before approval

Next
Next

Health experts urge FDA to approve over-the-counter birth control in unanimous vote